Skin Cancer
01/18/12 | by admin | Skin Care Info | No Comments »-->Melanoma is the deadliest form of skin cancer. I saw today that there is a drug that patients wit Melanoma can now take, newly approved, called vemurafenib (Zelboraf). Vemurafenib has been hailed as a breakthrough in the treatment of melanoma.
Aug. 17, 2011 — The FDA today approved Zelboraf, a drug that canextend survival for the 50% of melanoma patients whose tumors carry the BRAF V600E mutation.
Zelboraf is approved for inoperable or late-stage melanoma that tests positive for the BRAF mutation. In concert with the drug approval, the FDA also approved a new test for the BRAF mutation.
Skin Cancer Information – SkinCancer.org Take a Look.
Are you aware of this news? Jump in Melanoma Cases Expected in 2012 – SkinCancer.org
Zelboraf does not cure melanoma, which this year will kill some 9,000 Americans. But Zelboraf will make a big difference in the lives of BRAF-positive melanoma patients, says Anna Pavlick, DO, co-director of the melanoma program at New York University’s Cancer Institute. Pavlick was one of the investigators in Zelboraf clinical trials.
Good News, but of course a BUMP in the Newly approved drug road. Today this news came out. “Roughly one-quarter of patients who take the medication develop a troublesome side effect: secondary skin cancers called squamous cell carcinomas.”
US News / HEALTH Melanoma Drug’s Link to Other Skin Cancers Identified – US News and World Report



![[f]](/wp-content/uploads/2010/11/image92.png)
![[t]](/wp-content/uploads/2010/11/image112.png)
![[r]](/wp-content/uploads/2010/11/image93.png)
Leave a Reply